Net Sales at Rs 0.01 crore in December 2024 down 91.19% from Rs. 0.15 crore in December 2023. Quarterly Net Loss at Rs. 0.12 ...

Quarterly Net Profit at Rs. 1.75 crore in December 2024 up 1062.33% from Rs. 0.18 crore in December 2023. EBITDA stands at Rs ...

Quarterly Net Profit at Rs. 91.04 crore in December 2024 up 38.34% from Rs. 65.81 crore in December 2023. EBITDA stands at Rs ...

Net Sales at Rs 502.22 crore in December 2024 up 13.43% from Rs. 442.76 crore in December 2023. Quarterly Net Profit at Rs.

EBITDA stands at Rs. 2,696.78 crore in December 2024 up 34.08% from Rs. 2,011.28 crore in December 2023. Discover the latest ...

Quarterly Net Profit at Rs. 53.33 crore in December 2024 up 8.42% from Rs. 49.19 crore in December 2023. EBITDA stands at Rs.

Quarterly Net Profit at Rs. 108.12 crore in December 2024 up 110.73% from Rs. 51.31 crore in December 2023. EBITDA stands at ...

Quarterly Net Loss at Rs. 393.88 crore in December 2024 down 433% from Rs. 118.28 crore in December 2023. EBITDA stands ...

Redeem codes provide gamers with an avenue to acquire certain in-game treasures without spending any real money.

Mankind Pharma's Q3 net profit was impacted by the $1.6 billion acquisition of Bharat Serums and Vaccines (BSV), which came ...

UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy ...

Revlimid, which has arguably been the single biggest growth driver for Dr Reddy's in recent years, is set to go off patent in ...